References
- BERTINO, J., S., Jr. - RODVOLD, K., A., DESTACHE, C., J.: Cost consideration in therapeutic drug monitoring of aminoglycosides. Clin Pharmacokinet, 26, 1, 1994, p. 71 - 81.
- ROBERTS, J., A. - PATERSON, D., L.- MARTIN, J., H.: Therapeutic drug monitoring of antimicrobials. Br J Clin Pharmacol, 73, 1, 2012, p. 27 - 36.
- CONNORS, J., E. - DIPIRO J., T. - SISLEY J., F.: Use of serum concentration in surgical patients. Am J Surg 156, 1, 1988, p. 68 - 76.
- MIGNAVAL, F. - FONTAINE, P., A. - RICHÉ, A. - NOWAK, C. - CANCEL, D. - LEMAITRE, F.: A Priori prediction of gentamicin peak concentrations: Use of a simple and practical tool. PatholBiol (Paris) 59, 2, 2011, p. 79 - 82.
- VARON, J. - MARIK, P.: Management of the Obese Critically Ill Patient. Crit Care Clin 17, 1, 2001, p. 187 - 200.
- ROBERT, S. - ZAROWITZ, B.: Is there a reliable index of glomerular filtration rate in critically ill patients? DICP Ann Pharmacother 25, 2, 1991, p. 169 - 178.
- SAWYER W., T. - CANADAY, B., R. - POE, T., E.: Variables affecting creatinine prediction. Am J Hosp Pharm 40, 12, 1983, p. 2175 - 90.
- EVANS, W., E -OELRICH, M. - HOLTZ, D., W.: Therapeutic Drug Monitoring. Clinical Guide. 2 ed. Wiesbaden, Germany. ABBOTT Laboratory, Diagnostic Division, 1994, 160 p.
- MURPHY, J., E.: Clinical Pharmacokinetics. 4th edition Bethesda, Maryland: American Society Health - System Pharmacists, Publishing, 2008, p. 463.
- DESOKY, E., E. - KLOTZ, U.: Value, limitations and clinical impact of therapeutic drug monitoring in adults. Drug Invest 6, 3, 1993, p. 127 -136.
- THOMSON, A., H. - DUNCAN, N. - SILVERSTEIN, B. - ALCOCK, S. - JODRELL, D.: Development of guide lines for gentamicin dosing. J Antimicrob Chemother 38, 5, 1996, p.885 - 893.
- GÖBOÖVÁ, M. - MAGULOVÁ, L.: Use of TDM for optimal gentamicin therapy. Acta Chemother 10, 4-5, 2001, p.89 - 93.
- MAGULOVÁ, L. - VIRÁG, Ľ. - GÖBOÖVÁ, M.: Interpretation of results of therapeutic monitoring levels of gentamicin. (In Slovak). Acta Chemother 16, 5, 2006, p. 49 - 50.
- ISMAIL, R. - SARRRIFF, A. - ABDUL RAHMAN, A., F.: Therapeutic drug monitoring for gentamicin in Hospital Universiti Sains Malaysia. Med J Malaysia, 45, 1, 1990, p. 57-64.
- ISMAIL, R. - HAQ, A., H. - RAHMAN, A., F.: Therapeutic drug monitoring of gentamicin: a 6-year follow-up audit. J Clin Ther 22, 1, 2001, p. 21-25.
- LAM, F., Y., W. - Banerji, S. - Hatfield, C. - Talbert, R., L.: Principles of drug administration in renal insufficiency. Clin Pharmacokinetic 32, 1, 1997, p. 30 - 57.
- PAI, M., P. - NAFZIGER, A., N.- BERTINO, J., S.: Simplified estimation of aminoglycoside pharmacokinetics in underweight and obese adult patients. Antimicrob Agents Chemother 55, 9, 2011, p. 4006 - 4011.
- LEYKIN, Y. - MIOTTO, L. - PELLIS, T.: Pharmacokinetic considerations in the obese. Best Pract Res Clin Anaesthesiol 25, 1, 2011, p. 27 -36.
- PAI, M., P.: Estimating the glomerular filtration rate in obese adult patients for drug dosing. Adv Chronic Kidney Dis. 17, 5, 2010, p. 53 - 62.
- SALAZAR, D., E. - CORCORAN, G., B.: Predicting creatinine clearance and renal drug clearance in obese patients from estimated fat free body mass. Am J Med 84, 6, 1988, p. 1053 - 1060.
- DHILLON, S. - KOSTRZEWSKI, A.: Clinical Pharmacokinetics. 1st edition London, Chicago: Pharmaceutical Press, Publishing, 2006, p. 262.
- TOD, M., M. - PADOIN, C. - PETITJEAN, O.: Individualising aminoglycosides dosage regimens after therapeutic drug monitoring: simple or complex pharmacokinetic methods? Clin Pharmacokinet 40, 11, 2001, p. 803 - 814.